Structure Therapeutics Inc.
GPCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001888886
No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Structure Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +10 vs. Q1 2023
- Shares held
- 17.6M
- +2.89M (+19.6%) vs. Q1 2023
- Total value
- $699.4M
- +$353.2M (+102.0%) vs. Q1 2023
- New holders
- 14
- 11 more added
- Sold out
- 4
- 10 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GPCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $3.62B |
| Q1 2026 | 198 | $3.24B |
| Q4 2025 | 199 | $4.58B |
| Q3 2025 | 158 | $1.59B |
| Q2 2025 | 173 | $1.14B |
| Q1 2025 | 151 | $990.4M |
| Q4 2024 | 165 | $1.65B |
| Q3 2024 | 161 | $2.70B |
| Q2 2024 | 167 | $2.38B |
| Q1 2024 | 119 | $1.89B |
| Q4 2023 | 122 | $1.75B |
| Q3 2023 | 84 | $1.64B |
| Q2 2023 | 48 | $699.4M |
| Q1 2023 | 38 | $375.9M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Structure Therapeutics Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 2,646,782 | $110.0M | 5.14% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,773,350 | $73.7M | 0.01% | +986,845+125.5% | Added |
| BVF Inc | 1,750,000 | $72.7M | 2.03% | 00.0% | Unchanged |
| FMR LLC | 1,237,735 | $51.5M | 0.00% | −11,691−0.9% | Reduced |
| Driehaus Capital Management LLC | 1,135,936 | $47.2M | 0.60% | +195,708+20.8% | Added |
| Federated Hermes, Inc. | 1,014,700 | $42.2M | 0.10% | −38,102−3.6% | Reduced |
| Casdin Capital, LLC | 997,017 | $41.4M | 3.62% | +320,000+47.3% | Added |
| T. Rowe Price Investment Management, Inc. | 654,516 | $27.2M | 0.02% | +56,408+9.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 627,813 | $26.1M | 0.56% | +252,813+67.4% | Added |
| Cormorant Asset Management, LP | 576,373 | $24.0M | 1.36% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 1,370,991 | $22.8M | 5.43% | +1,200,991+706.5% | Added |
| Point72 Asset Management, L.P. | 431,000 | $17.9M | 0.06% | +81,138+23.2% | Added |
| Logos Global Management LP | 400,000 | $16.6M | 2.30% | +50,000+14.3% | Added |
| Jennison Associates LLC | 399,780 | $16.6M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 394,846 | $16.4M | 0.00% | −5,154−1.3% | Reduced |
| TCG Crossover Management, LLC | 350,000 | $14.5M | 2.39% | 00.0% | Unchanged |
| Citadel Advisors LLC | 349,663 | $14.5M | 0.02% | −16,624−4.5% | Reduced |
| Franklin Resources Inc | 250,809 | $10.4M | 0.00% | −74,191−22.8% | Reduced |
| Wellington Management Group LLP | 210,269 | $8.74M | 0.00% | +110,370+110.5% | Added |
| Adage Capital Partners GP, L.L.C. | 192,398 | $8.00M | 0.02% | −100,000−34.2% | Reduced |
| Woodline Partners LP | 170,000 | $7.07M | 0.08% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 77,430 | $3.22M | 0.00% | −268,991−77.6% | Reduced |
| Octagon Capital Advisors LP | 75,000 | $3.12M | 0.44% | −18,692−20.0% | Reduced |
| TD Asset Management Inc | 72,709 | $3.02M | 0.00% | +36,763+102.3% | Added |
| Nantahala Capital Management, LLC | 50,000 | $2.08M | 0.25% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 50,000 | $2.08M | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 44,226 | $1.84M | 0.00% | +8,767+24.7% | Added |
| Prudential Financial Inc | 42,000 | $1.75M | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 40,631 | $1.69M | 0.00% | +40,631 | New |
| Avidity Partners Management LP | 37,800 | $1.57M | 0.05% | +37,800 | New |
| SVB Financial Group | 35,353 | $1.47M | 2.78% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 32,900 | $1.37M | 0.00% | +32,900 | New |
| China Universal Asset Management Co., Ltd. | 27,267 | $1.13M | 0.35% | +27,267 | New |
| Maven Securities LTD | 25,000 | $1.04M | 0.15% | +25,000 | New |
| Lynx1 Capital Management LP | 23,000 | $956.1K | 0.63% | 00.0% | Unchanged |
| Weiss Multi-Strategy Advisers LLC | 15,173 | $631.0K | 0.01% | +15,173 | New |
| Platinum Investment Management Ltd | 15,000 | $623.5K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 11,460 | $476.4K | 0.00% | +11,460 | New |
| Fred Alger Management, LLC | 10,512 | $437.0K | 0.00% | +10,512 | New |
| Geode Capital Management, LLC | 10,257 | $426.4K | 0.00% | +10,257 | New |
| UBS Oconnor LLC | 10,193 | $423.7K | 0.01% | −11,857−53.8% | Reduced |
| Virtus ETF Advisers LLC | 3,513 | $146.0K | 0.09% | +3,513 | New |
| Bank of America Corp | 1,684 | $70.0K | 0.00% | +1,684 | New |
| Barclays PLC | 1,132 | $47.1K | 0.00% | +1,132 | New |
| Pinpoint Asset Management Ltd | 900 | $37.0K | 0.00% | +900 | New |
| Signaturefd, LLC | 100 | $4.16K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 67 | $2.79K | 0.00% | −33−33.0% | Reduced |
| UBS Group AG | 2 | $83 | 0.00% | +2 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −8,474−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −805−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −11−100.0% | Sold out |